[Psychedelic] patents may limit access
Given promising clinical-trial results, many stakeholders are attempting to patent psychedelic compounds and methods of producing and administering them… the sudden interest in patenting psychedelics has prompted criticism from stakeholders, including patient advocates, scientists, journalists, lawyers and Indigenous communities… Weak psychedelic patents could potentially be invalidated in court, but that does not make them harmless,…
Recent Comments